Vanguard Group Inc Clear Point Neuro, Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,497,637 shares of CLPT stock, worth $23.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,497,637
Previous 1,475,120
1.53%
Holding current value
$23.2 Million
Previous $17.6 Million
85.29%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding CLPT
# of Institutions
114Shares Held
8.38MCall Options Held
437KPut Options Held
199K-
Geode Capital Management, LLC Boston, MA656KShares$10.2 Million0.0% of portfolio
-
State Street Corp Boston, MA483KShares$7.48 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.68 Million0.0% of portfolio
-
Ubs Group Ag361KShares$5.59 Million0.0% of portfolio
-
Brown Advisory Inc331KShares$5.12 Million0.01% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $379M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...